TAK
Takeda Pharmaceutical Company Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · JP
$21.06
+1.49%Forward multiples
Based on analyst estimates
- P/E forward
- 25.86x
- P/E 2026E
- 43.48x
- P/E 2027E
- 32.42x
- P/E 2028E
- 26.38x
- P/S forward
- 2.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- 27.34x
- PEG TTM
- 4.74x
- Price / book
- 1.44x
- Price / sales
- 2.26x
- Price / cash flow
- 12.86x
Enterprise value
- Enterprise value
- $93.5B
- EV / sales
- 3.13x
- EV / EBITDA
- 11.20x
- EV / EBIT
- 22.87x
- Market cap
- $67.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026